drug · small molecule
patient view →nimodipine
Marketedupdated 2mo agoby $GRCE Grace Therapeutics, Inc.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for cardiovascular disease and 10 investigational indications.
targets
Mineralocorticoid receptorVoltage-gated L-type calcium channel
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that